GRIFOLS | GRF - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Alcon AG USD 1.69B 175M 2026-03
Almirall EUR 429.87M 180.02M 2025-12
Amadeus IT EUR 754.9M 225.7M 2026-03
Amarin USD 23.17M 961K 2025-12
argenx SE USD 1.18B 40.98M 2026-03
AstraZeneca USD 12.61B 225M 2026-03
Bayer EUR 6.94B 1.58B 2025-12
Cie Automotive EUR 805.54M 79.61M 2024-12
Demant DKK 8.82B 277M 2025-12
Ence Energia y Celulosa EUR 64M 117.3M 2026-03
Essilor EUR 8.3B 547M 2025-12
Ferrovial EUR 4.27B 498M 2024-12
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.18B 210M 2026-03
Genmab DKK 977M 13M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
GRIFOLS EUR 686.84M 56.95M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Inditex EUR 5.36B 1.05B 2026-03
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Merck EUR 3.07B 104M 2026-03
Novartis USD 10.07B 184M 2026-03
Philips EUR 1.77B 522M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
UCB EUR 3.19B 621M 2025-12
Viscofan EUR 112.29M 226K 2026-03